featured news

feature 1

featured news

Monday, September 19, 2022

CPHI 2022 Frankfurt

read more

feature 2

featured news

feature 3

featured news

Thursday, May 12, 2022

Line 3 Mock-up

read more

feature 4

featured news

feature 5

featured news

feature 6

featured news

Tuesday, September 8, 2020

central workplaces

read more

feature 8

our technological excellence as a CDMO

We are oncomed – a Contract Development and Manufacturing Organization (CDMO) specialized in aseptic processing of oncology injectables in clinical and commercial scales. We deliver drugs with high potent and cytotoxic characteristics to fight cancer, worldwide.

organic solvents handling

high-potent APIs

single-use systems

sensitive API handling

5 reasons why choose oncomed

5 reasons why choose oncomed

employee skills & mindset

We believe that thanks to our knowledge, flexible approach and endeavour to look for the solution, we may fully support a clients in their needs.

variety of niche technologies

We believe that thanks to our brave approach and state-of-the-art technology, our clients can dare to act with courage too and ask for advanced highly active drug solutions. We (and our technology) will support them.

supply risk mitigation

We understand the cost and time pressures faced by pharmaceutical companies, therefore we offer flexible, affordable, and rapid outsourcing services designed to meet specific needs of our customers.

access to free manufacturing capacity

We offer two fully operational lines. We also keep investing into manufacturing capacity and state-of-the-art technologies. Line 3 that will offer highly advanced solutions is in construction.

no additional major investments

We offer various vial formats, variable equipment sizes and qualified processes. We also take pride in our transparent service offerings that lower any additional investments to a mere minimum.

employee skills & mindset

We believe that thanks to our knowledge, flexible approach and endeavour to look for the solution, we may fully support a clients in their needs.

variety of niche technologies

We believe that thanks to our brave approach and state-of-the-art technology, our clients can dare to act with courage too and ask for advanced highly active drug solutions. We (and our technology) will support them.

supply risk mitigation

We understand the cost and time pressures faced by pharmaceutical companies, therefore we offer flexible, affordable, and rapid outsourcing services designed to meet specific needs of our customers.

access to free manufacturing capacity

We offer two fully operational lines. We also keep investing into manufacturing capacity and state-of-the-art technologies. Line 3 that will offer highly advanced solutions is in construction.

no additional major investments

We offer various vial formats, variable equipment sizes and qualified processes. We also take pride in our transparent service offerings that lower any additional investments to a mere minimum.

upcoming events

news & stories

27. 10. 2022 | Articles News

Completion of WWT unit testing

During September, we at oncomed completed the testing of a WWT (waste water technology) unit. This unit will be used to decontaminate our waste water from individual workplaces
read text
19. 9. 2022 | Articles Events

CPHI 2022 Frankfurt

Are you going to attend CPHI this year? Read the article why you should consider participation, who can you meet there from oncomed and where to contact us for a meeting.
read text
19. 8. 2022 | Articles

Stability studies moved to new premises

oncomed has moved the premises for stability studies to a new building, which has significantly increased the storage capacity.
read text